Four things to know:
1. The companies entered into the agreement in January 2017.
2. DePuy’s orthopedic representatives collaborated with Pacira’s field teams to promote Exparel in orthopedic surgical settings. Pacira’s field representatives remained the overall account managers and commercial leads for soft tissue surgeons, anesthesiologists and ambulatory surgery centers.
3. Pacira CEO and chair Dave Stack spoke highly of the partnership but said Pacira developed in-house capabilities to handle promotion in orthopedic surgical settings. Pacira, now, has a large salesforce trained to promote Exparel in these settings.
4. To get out of the agreement, Pacira will pay DePuy an early termination fee.
More articles on devices:
19 spine facilities opening in 2020
153+ ASCs with spine surgery | 2020
DePuy Synthes, AO Foundation extend 60-year orthopedic partnership
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.